Clinical Trial Update: CPAP to Treat Cognitive Dysfunction in MS [NA]

View source ↗

Summary

Clinical trial investigating CPAP treatment for cognitive dysfunction in multiple sclerosis has completed, with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• CPAP (Continuous Positive Airway Pressure)

Snippet

Sponsor: University of Michigan | Conditions: Multiple Sclerosis | NA | Status: COMPLETED | Results posted: 2022-09-14